Stay updated on Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing Revision: v3.6.0, indicating a recent platform update. This reflects an underlying version change rather than substantive content changes.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew navigation/help sections have been added to the page, including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment label. The site revision badge has been updated to Revision: v3.6.0, with the older Revision: v3.5.5 removed.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page now shows Revision: v3.5.5 indicating an updated version, and no trial details or results are affected.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page shows a new revision number (v3.5.4) replacing the previous v3.5.3, indicating a minor internal update to the page's documentation.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page metadata/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3” without changing the study’s substantive details.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.